Treatment of Staphylococcus aureus catheter-related infection and infective endocarditis with granulocyte colony-stimulating factor in the experimental rabbit model

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 5, 1996, Pages 1308-1310

  Frank, Uwe ^a,b   Chambers, Henry F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL ENDOCARDITIS; CATHETER INFECTION; DRUG EFFICACY; HEART CATHETER; IMMUNOTHERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKOCYTOSIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0029867231     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.5.1308     Document Type: Article

References (22)

1. Cairo, M. S., D. Mauss, S. Kommareddy, K. Norris, C. Van De Ven, and H. Modanlou. 1990. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats. Pediatr. Res. 27:612-616.
2. Clark, S. C., and R. Kamen. 1987 The human hematopoietic colony-stimulating factors. Science 236:1229-1237.
3. Daifuku, R., J. Andresen, and G. Morstyn. 1993. Rccombinant methionyl human granulocyte colony-stimulating factor for the prevention and treatment of non-neutropenic infectious diseases J. Antimicrob. Chemother. 32(Suppl. A):91-97
4. Freedman, L. R. 1982 Host defense mechanisms, p. 125-136. In L. R. Freedman (ed.), Infective endocarditis and other intravascular infections. Plenum Medical Book Company, New York.
5. Hassard, T. H. 1991. Understanding biostatistics. Mosby-Year Book. Inc., St. Louis. Mo.
6. Iguchi, K., S. Inoue, and A. Kumar. 1991. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats. Exp. Hematol. 19:352-358.
7. Mooney, D. P., R. L. Gamelli, M. O'Reilly, and J. C. Hebert. 1988. Recombinant human granulocyte colony-stimulating factor and Pseudomonas burn wound sepsis. Arch Surg. 123:1353-1357.
8. Nelson, S. 1994. Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the non-neutropenic host: an overview. Clin. Infect. Dis. 18(Suppl. 2):S197-S204.
9. Perlman, B. B., and L. R. Freedman. 1971. Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J Biol. Med. 44:206-224.
10. Repine, J. E., C. C. Clawson, H. B. Burchell, and J. G. White. 1976. Reversible neutrophil defect in patients with bacterial endocarditis. J Lab Clin Med. 88:780-787.
11. Riba, A. L., M. L. Thakur, A. Gottschalk, V. T. Andriole, and B. L. Zaret. 1979 Imaging experimental infective endocarditis with indium-111-labeled blood cellular components Circulation 59:336-343.
12. Roilides, E., T. J. Walsh, P. A. Pizzo, and M. Rubin. 1991. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J. Infect. Dis. 163:579-583.
13. Sahm, D. F., and J. A. Washington II. 1991. Antibacterial susceptibility tests: dilution methods, p. 1105-1116. In A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H J Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
14. Sherertz, R. J., I. I. Raad, A. Belani, L. C. Koo, K. H. Rand, D. L. Pickett, S. A. Straub, and L. L. Fauerbach. 1990. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J. Clin. Microbiol. 28:76-82.
15. Silver, G. M., R. L. Gamelli, and M. O'Reilly. 1989 The beneficial effect of granulocyte colony stimulating factor in combination with gentamicin on survival after Pseudomonas bum wound infection. Surgery 106:452-456.
16. Souza, L. M., T. C. Boone, J. Gabrilove, P. H. Lari, K. M. Zsebo, D. C. Murdock, V. R. Chazin, J. Bruszewski, H. Lu, and K. K. Chen. 1986. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 232:61-65.
17. Steckelberg, J. M., M. S. Rouse, B. M. Tallan, D. R. Osmon, N. K. Henry, and W. R. Wilson. 1993. Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis. Antimicrob. Agents Chemother. 37:554-558.
18. Sullam, P. M., U. Frank, M. R. Yeaman, M. G. Täuber, A. S. Bayer, and H. F. Chambers. 1993 Effect of thrombocytopenia on the early course of streptococcal endocarditis. J. Infect Dis. 168:910-914.
19. Vaudaux, P., D. Pittet, A. Haeberli, E. Huggler, U. E. Nydegger, D. P. Lew, and F. A. Waldvogel. 1989. Host factors selectively increase Staphylococcal adherence on inserted catheters: a role for fibronectin and fibrinogen or fibrin. J Infect Dis 160:865-575.
20. Vose, J. M., and J. O. Armitage. 1995. Clinical applications of hematopoietic growth factors. J. Clin. Oncol 13:1023-1035.
21. Yasuda, H., Y. Ajiki, T. Shimozato, M. Kasahara, H. Kawada, and M. Iwata. 1990. Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice. Infect. Immun. 58:2502-2509.
22. Zimmerli, W., P. D. Lew, and F. A. Waldvogel. 1984 Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J. Clin. Invest. 73:1191-1200.